Efficient antitumor immunity in a murine colorectal cancer model induced by CEA RNA-electroporated B cells

European Journal of Immunology

Volumn 38, Issue 8, 2008, Pages 2106-2117

  Park, Mi Young ^a   Kim, Hye Sung ^a   Woo, Sun Je ^a   Kim, Chang Hyun ^a   Park, Jung Sun ^a   Sohn, Hyun Jung ^a   Kim, Hyung Jin ^a   Oh, Seong Taek ^a   Kim, Tai Gyu ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

B cells; Carcinoembryonic antigen; Dendritic cells; RNA electroporation

Indexed keywords

B LYMPHOCYTE VACCINE; CANCER VACCINE; CARCINOEMBRYONIC ANTIGEN; DENDRITIC CELL VACCINE; GAMMA INTERFERON; RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CANCER IMMUNIZATION; CANCER INHIBITION; CANCER SURVIVAL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; COLORECTAL CANCER; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DENDRITIC CELL; ELECTROPORATION; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR IMMUNITY; VACCINATION; ANIMAL; ANTIGEN PRESENTATION; C57BL MOUSE; COLORECTAL TUMOR; DISEASE MODEL; GENE TRANSFER; IMMUNOLOGY; METABOLISM;

ANIMALS; ANTIGEN PRESENTATION; B-LYMPHOCYTES; CANCER VACCINES; CARCINOEMBRYONIC ANTIGEN; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COLORECTAL NEOPLASMS; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; ELECTROPORATION; FEMALE; GENE TRANSFER TECHNIQUES; MICE; MICE, INBRED C57BL; RNA; VACCINATION;

EID: 51149116556     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200737960     Document Type: Article

References (40)

1. Maier, T., Tun-Kyi, A., Tassis, A., Jungius, K. P., Burg, G., Dummer, R. and Nestle, F. O., Vaccination of patients with cutaneous T-cell lymphoma using intranodal injection of autologous tumor-lysate-pulsed dendritic cells. Blood 2003. 102: 2338-2344.
2. Kugler, A., Stuhler, G., Walden, P., Zoller, G., Zobywalski, A., Brossart, P., Treher, U. et al., Regression of human metastatic renal cell carcinoma after waccination With tumor cell-dendritic cell hybrids. Nat. Med. 2000. 6: 332-336.
3. Banchereau, J., Palucka, A. K., Dhodapkar, M., Burkeholder, S., Taquet, N., Rolland, A., Taquet, S. et al., Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine. Cancer Res. 2001. 61: 6451-6458.
4. Boczkowski, D., Nair, S. K., Nam, J. H., Lyerly, H. K. and Gilboa, E., Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cells. Cancer Res. 2000. 60: 1028-1034.
5. Heiser, A., Maurice, M. A., Yancey, D. R., Wu, N. Z., Dahm, P., Pruitt, S. K., Boczkowski, D. et al., Induction of polyclonal prostate cancer-specific CTL using dendritic cells transfected with amplified tumor RNA. J. Immunol. 2001. 166: 2953-2960.
6. Milazzo, C., Reichardt, V. L., Muller, M, R., Grunebach, F. and Brossart, P., Induction of myeloma-specific cytotoxic T cells using dendritic cells transfected with tumor-derived RNA. Blood 2003. 101: 977-982.
7. Steinman, R. M,, Witmer-Pack M. and Inaba, K., Dendritic cells: Antigen presentation, accessory function and clinical relevance. Adv. Exp. Med. Biol. 1993. 329: 1-9.
8. Schultze, J. L., Grabbe, S. and von Bergwelt-Baildon, M. S., DCs and CD40-activated B cells: Current and future avenues to cellular cancer immunotherapy. Trends Immunol. 2004. 25: 659-664.
9. Schultze, J. L., Michalak S., Seamon, M. J., Dranoff, G., Jung, K., Daley, J., Delgado, J. C. et al., CD40-aLtivated human B cells: An alternative source of highly efficient antigen presenting cells to generate autologous antigenspecific T cells for adoptive immunotherapy. J. Clin. Invest. 1997. 100: 2757-2765.
10. Verthelyi, D. and Zeunex, R. A., Differential signaling by CpG DNA in DCs and B cells: Not just TLR9. Trends Immunol. 2003. 24: 519-522.
11. Chung, Y., Kim, B. S., Kim, Y. J., Ko, H. J., Ko, S. Y., Kim, D. H. and Kang, C. Y., CD1d-restricted T cells license B cells to generate long-lasting cytotoxic antitumor immunity in vivo. Cancer Res. 2006. 66: 6843-6850.
12. Gerloni, M., Rizzl, M., Castiglioni, P. and Zanetti, M., T cell immunity using transgenic B lymphocytes. Proc. Natl. Acad. Sci. USA 2004. 101: 3892-3897
13. Van den Bosch, G. A., Ponsaerts, P., Nijs, G., Lenjou, M., Vanham, G., Van Bockstaele, D. R., Berneman, Z. N. et al., Ex vivo induction of viral antigenspecific CD8 T cell responses using m-RNA-electroporated CD40-activated B cells. Clin Exp. Immunol. 2005. 139: 458-467.
14. Coughlin, C. M., Vance, B. A., Grupp, S. A. and Vonderheide, R. H., RNAtransfected CD40-activated B cells induce functional T-cell responses against virol and tumor antigen targets: Implications for pediatric immunotherapy. Blood 2004. 103: 2046-2054.
15. Thompson, J. A., Grunert, F. and Zimmermann, W., Carcinoembryonic antigen gene family: Molecular biology and clinical perspectives. J. Clin. Lab. Anal. 1991. 5: 344-366.
16. Oh, S. T., Kim, C. H., Park, M. Y., Work, E. H., Sohn, H. J., Cho, H. L, Kang, W. K. et al., Dendritic cells transduced with recombinant adenoviruses induce more efficient anti-tumor immunity than dendritic cells pulsed with peptide. Vacine 2006. 24: 2860-2868.
17. Aldrich, W. A., Ren, C, White, A. F., Zhou, S. Z., Kumar, S., Jenkins, C. B., Shaw, D. R. et al., Enhanced transduction of mouse bone marrow-derived dendritit cells by repetitive infection with self-complementary adenoassociated virus 6 combined with immunostimulatory ligands. Gene Ther. 2006. 13: 29-39.
18. Hörig, H., Medina, F. A., Conkright, W. A. and Kaufman, H. L., Strategies for cancer therapy using carcinoembryonic antigen vaccines. Expert. Rev. Mol. Med. 2000. 2: 1-24.
19. Cho, H. I., Kim, H. J., Oh, S. T. and Kim, T. G., In vitro induction of carcinoembryonic antigen (CEA)-specific cytotoxic T lyrnphocytes by dendritic cells transduced with recombinant adenoviruses. Vaccine 2003. 22: 224-236.
20. Eynon, E. E. and Parker, D. C., Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens. J. Exp. Med. 1992. 175: 131-138.
21. Bennett, S. R., Carbone, F. R., Toy, T., Miller, J. F. and Heath, W. R., B cells directly tolerize CD8(+) T cells. J. Exp. Med. 1998. 188: 1977-1983.
22. Qin, Z., Richter, G., Schüler, T., Ibe, S., Cao, X. and Blankenstein, T., B cells inhibit induction of T cell-dependent tumor immunity. Nat. Med. 1998. 4: 627-630.
23. Iwasaki, A. and Medzhitov, R., Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 2004. 5: 987-995.
24. Takeda, K., Kaisho, T. and Akira, S., Toll-like receptors. Annu. Rev. Immunol. 2003. 21: 335-376.
25. + dendritic cell subset selectivelv endocytoses dying cells in culture and in vivo. J. Exp. Med. 2002. 195: 1289-1302.
26. Keindienst, P. and Brocker, T., Endogenous dendritic cells are required for amplification of T cell responses induced by dendritic cell vaccines in vivo. J. Immunol. 2003. 170: 2817-2823.
27. Russo, V., Cipponi, A., Raccosta, L., Rainelli, C., Fontana, R., Maggioni, D., Lunghi, F. et al., Lymphocytes genetically modified to express tumor antigens target DCs in vivo and induce antitumor immunity. J. Clin. Invest. 2007. 117. 3087-3096.
28. De Vries, I. J., Krooshoop, D. J., Scharenborg, N. M., Lesterhuis, W. J., Diepstra, J.H., Van Muijen, G.N., Strijk, S.P. et al., Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state. Cancer Res. 2003. 63: 12-17.
29. Okada, T., Ngo, V. N., Ekland, E. H., Förster, R., Lipp, M., Littman, D. R. and Cyster, J. G., Chemokine requirements for B cell entry to lymph nodes and Peyer's patches. J. Exp. Med. 2002. 196: 65-75.
30. Ron, Y. and Sprent, J., T cell priming in vivo: A major role for B cells in presenting antigen to T cells in lymph nodes. J. Immunol. 1987. 138: 2848-2856.
31. Zanetti, M., Castiglioni, P., Rizzi, M., Wheeler, M. and Gerloni, M., B lymphocytes as antigen-presenting cell-based genetic vaccines. Immunol. Rev. 2004. 199: 264-278.
32. von Bergwelt-Baildon, M. S., Vonderbeide, R. H., Maecker, B., Hirano, N., Anderson, K. S., Butler, M. O., Xia, Z. et al., Human primary and memory cytotoxic T lymphocyte responses are efficiently induced by means of CD40-activated B cells as antigen-presenting cells: Potential for clinical application. Blood 2002. 99: 3319-3325.
33. Kyte, J. A., Mu, L., Aamdal, S., Kvalheim, G., Dueland, S., Hauser, M., Gullestad, H. P. et al., Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA. Cancer Gene. Ther. 2006. 13: 905-918.
34. Castiglioni, P., Gerloni, M., Cortez-Gonzalez, X. and Zanetti, M., CD8 T cell priming by B lymphocytes is CD4 help dependent. Eur. J. Immunol. 2005. 35: 1360-1370.
35. Woodland, D. L., Jump-starting the immune system: Prime-boosting comes of age. Trends Immunol. 2004. 25: 98-104.
36. + T-cell memory and prime-boost response after dendritic-cell vaccination. Nat. Med. 2005. 11: 748-756.
37. Robbins, P. F., Kantor, J. A., Salgaller, M., Hand, P. H., Fernsten, P. D. and Schlom, J., Transduction and expression of the human carcinoembryonic antigen gene in a murine colon carcinoma cell line. Cancer Res. 1991. 51: 3657-3662.
38. Inaba, K., Turley, S., Yamaide, F., Iyoda, T., Mahnke, K., Inaba, M., Pack, M. et al., Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J. Exp. Med. 1998, 188: 2163-2173.
39. Helser, A., Dahm, P., Yancey, D. R., Maurice, M. A., Boczkowski, D., Nair, S. K., Gilboa, E. et al., Human dendritic cells transfected with RNA encoding prostate-specific antigen stimulate prostate-specific CTL responses in vitro. J. Immunol. 2000. 164: 5508-5514.
40. Colvin, G. A., Lambert, J. F., Dooner, M. S., Cerny, J. and Quesenberry, P. J., Murine allogeneic in vivo stem cell homing. J. Cell Physiol. 2007. 211: 386-391.